PR

ProBiotix Health Plc

Develops and supplies probiotic solutions for cardiometabolic health and healthy aging.

PBX | Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BLNBFR86
LEI:
98450048683CF0388C30
Country:
United Kingdom
Address:
First Floor Zucchi Suite, WF4 1AB Wakefield

Description

ProBiotix Health Plc is a life sciences company that develops and supplies scientifically validated, probiotic-based microbiome solutions. The company specializes in formulations for cardiometabolic health, targeting conditions related to cholesterol, blood pressure, and vascular health, as well as healthy aging. Its core technology is LPLDL®, a patented and trademarked Lactobacillus plantarum strain demonstrated in human clinical trials to be effective in managing key cardiometabolic markers. ProBiotix Health offers its technology as both a raw ingredient and in finished product formulations, such as the YourBiotix and CholBiome® lines, for the global dietary supplement market. The company's approach is rooted in extensive research and development, conducted in collaboration with universities and scientific advisors to ensure product efficacy and safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-16 08:00
New Commercial Partnership in Greece
English 14.1 KB
2024-09-06 15:08
Response to OptiBiotix Health plc announcement
English 11.6 KB
2024-09-04 08:00
Share Subscription and Proposed Board Appointment
English 13.9 KB
2024-08-30 08:00
Half-year Report
English 195.3 KB
2024-08-15 08:00
New commercial partnership agreement in China
English 14.0 KB
2024-08-08 15:14
Result of AGM
English 10.9 KB
2024-07-29 08:00
New appointment
English 13.2 KB
2024-07-15 08:00
Six month trading update
English 15.0 KB
2024-06-28 08:00
Final Results
English 588.6 KB
2024-02-26 08:00
Partner agreement with SymbioPharm
English 13.2 KB
2024-02-09 08:00
Change of auditor
English 10.6 KB
2024-01-31 08:00
New appointment
English 12.4 KB
2024-01-11 08:00
Directorate Change
English 13.5 KB
2023-09-27 08:00
Half-year Report
English 206.6 KB
2023-08-01 08:00
Distribution agreement
English 12.8 KB

Automate Your Workflow. Get a real-time feed of all ProBiotix Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ProBiotix Health Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ProBiotix Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.